References
- Pearlstein T. Prevalence, impact, on morbidity and burden of disease. In O’Brien PMS, Rapkin A, Schmidt P, eds. The Premenstrual Syndromes: PMS and PMDD. London: Informa Healthcare, 2007:37–47
- Chung SH, Kim TH, Lee HH, et al. Premenstrual syndrome and premenstrual dysphoric disorder in perimenopausal women. J Menopausal Med 2014;20:69–74
- O’Brien PMS, Bäckström T, Brown C, et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Women's Ment Health 2011;14:13–21
- Nevatte T, O’Brien PM, Bäckström T, et al.; Consensus Group of the International Society for Premenstrual Disorders. ISPMD consensus on the management of premenstrual disorders. Arch Women's Ment Health 2013;16:279–91
- RCOG Green Top Guideline No 48. The management of Premenstrual Syndrome Ed. Panay N, Dec 2007 http://www.rcog.org.uk/womens-health/clinical-guidance/management-premenstrual- syndrome-green-top-48